AI agents are changing how clinical decisions are made, workflows are optimized, and care is delivered across hospitals, labs, and telehealth systems. Learn how these tools can scale medical expertise, streamline bottlenecks, and improve patient outcomes—without replacing the human element. Hosted by Dr. Sanjay Juneja and featuring expert insights from Dr. Harvey Castro, this interview explains how digital twins, ambient AI, and agentic systems can support clinical judgment, reduce burnout, and personalize care at scale. You’ll also hear practical guidance on whether to build or buy AI tools, how to structure healthcare-specific data, and what integration actually looks like in high-pressure environments. If you’re in healthcare leadership, IT, operations, or product development, this discussion provides frameworks and real-world examples you can act on now.

AI is reshaping rare disease treatments by accelerating drug repurposing, identifying therapeutic opportunities, and unlocking actionable insights hidden in clinical data. Discover how innovative frameworks and technology platforms are helping healthcare leaders, diagnostic companies, and telehealth providers uncover new treatment pathways faster and more efficiently. Dr. Sanjay Juneja (https://sjunejamd.com/) speaks with Dr. David Fajgenbaum (https://www.linkedin.com/in/davidfajgenbaum) about the ethical imperative of using AI-driven drug repurposing to address underserved rare conditions and the growing potential to surface overlooked therapies. Gain practical insights on decision-making, data analysis, and scalable solutions that can impact patient care.

Unlock faster, smarter drug repurposing with open-source data that arms clinicians and researchers with actionable insights. This discussion explores how cutting-edge AI and knowledge graphs are transforming access to potential therapies by ranking 4,000 approved drugs against thousands of diseases - all in record time. Host Dr. Sanjay Juneja speaks with Dr. David Fajgenbaum, Co-founder of Every Cure, to reveal how their platform delivers 75 million computed drug-disease scores directly into the hands of healthcare providers worldwide. Learn how this approach accelerates clinical decision-making, supports evidence-based research, and breaks down barriers to innovative care strategies.